Valuation: Byotrol plc

Market Cap 194K 260K 228K 211K 366K 25.09M 372K 2.52M 985K 12.27M 976K 955K 42.27M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.13M 993K 919K 1.6M 109M 1.62M 10.98M 4.3M 53.49M 4.25M 4.16M 184M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 01/07/2024
Director TitleAgeSince
Director/Board Member 50 13/12/2021
Chairman 75 22/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
-0.57%+1.42%-3.85%-0.77% 349B
-0.73%+0.87%-7.13%+0.94% 135B
-0.56%-0.34%+5.86%+20.30% 74.4B
-0.19%-0.51%-14.05%-19.91% 52.31B
+0.21%-2.36%-13.55%-23.92% 36.44B
+1.84%+1.19%-4.09%-56.20% 29.71B
-0.53%+1.22%+14.54%-0.42% 19.89B
-0.50%+1.52%-26.48%-31.15% 19.85B
+0.70%+2.76%-1.17%+27.40% 18.43B
Average -1.97%+0.83%-5.55%-9.30% 81.74B
Weighted average by Cap. -0.11%+1.32%-4.73%-3.18%

Financials

2023 2024
Net sales 4.59M 6.17M 5.4M 5M 8.68M 595M 8.81M 59.71M 23.35M 291M 23.13M 22.64M 1B 3.97M 5.33M 4.67M 4.32M 7.5M 514M 7.62M 51.62M 20.19M 251M 20M 19.57M 866M
Net income -1.69M -2.27M -1.99M -1.84M -3.2M -219M -3.25M -22M -8.61M -107M -8.52M -8.34M -369M -3.06M -4.11M -3.6M -3.33M -5.79M -397M -5.88M -39.84M -15.58M -194M -15.43M -15.1M -668M
Net Debt 287K 385K 337K 312K 542K 37.17M 551K 3.73M 1.46M 18.17M 1.45M 1.41M 62.61M 651K 874K 766K 708K 1.23M 84.32M 1.25M 8.46M 3.31M 41.22M 3.28M 3.21M 142M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35